Peripheral Nerve Stimulators Market Outlook:
Peripheral Nerve Stimulators Market size was over USD 656.71 million in 2025 and is anticipated to cross USD 1.1 billion by 2035, growing at more than 5.3% CAGR during the forecast period i.e., between 2026-2035. In the year 2026, the industry size of peripheral nerve stimulators is assessed at USD 688.04 million.
The rising number of patients suffering from chronic pain conditions, including neuropathy, back pain, and migraines, as well as neurological disorders such as stroke and spinal cord injuries, is significantly increasing the demand for effective pain management solutions and propelling peripheral nerve stimulators market. According to a WHO report released in March 2024, the incidence of diabetic neuropathy patients worldwide has tripled since 1990, reaching 206 million cases in 2021. Peripheral nerve stimulators (PNS) are gaining popularity due to their non-invasive nature, providing targeted relief by directly stimulating nerves and alleviating pain. Their ability to specifically address pain without the need for invasive surgery or medications makes them a preferred choice.
Additionally, the global movement away from opioid medications, driven by growing concerns about addiction, dependency, and severe side effects, is significantly increasing the demand for non-pharmacological therapies like peripheral nerve stimulators (PNS). These devices provide an effective and safer alternative for managing pain, offering targeted relief without the risks linked to opioid use. As a result, the adoption by patients and healthcare providers, seeking better pain management solutions is increasing. Thus, propelling the Peripheral Nerve stimulators market.
